Alaunos Therapeutics, Inc.
TCRT
$2.63
-$0.05-1.87%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -35.18% | -31.67% | -40.58% | -31.62% | -49.25% |
Total Receivables | -- | -- | 300.00% | 0.00% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -11.14% | -15.56% | 16.92% | -13.97% | 137.62% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -22.39% | -24.11% | -22.51% | -26.92% | -35.81% |
|
|||||
Total Current Assets | -22.39% | -24.11% | -22.51% | -26.92% | -35.81% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -99.97% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -22.39% | -24.11% | -22.51% | -26.94% | -57.49% |
|
|||||
Total Accounts Payable | 12.66% | 25.48% | -38.86% | -3.08% | -52.54% |
Total Accrued Expenses | -52.17% | -32.10% | -15.71% | -52.01% | -56.37% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -16.22% | -8.93% | -26.85% | -36.61% | -58.17% |
|
|||||
Total Current Liabilities | -16.22% | -8.93% | -26.85% | -36.61% | -58.17% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | -16.22% | -8.93% | -26.85% | -36.61% | -64.69% |
|
|||||
Common Stock & APIC | 0.01% | 0.01% | 0.01% | 0.02% | 0.03% |
Retained Earnings | -0.08% | -0.12% | -0.12% | -0.18% | -0.86% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -24.27% | -27.76% | -21.39% | -23.94% | -54.63% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -24.27% | -27.76% | -21.39% | -23.94% | -54.63% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -24.27% | -27.76% | -21.39% | -23.94% | -54.63% |
|